RXII


Stock Update (NASDAQ:RXII): Here’s Why RXi Pharmaceuticals Corp Shares Rose 25%

RXi Pharmaceuticals Corp (NASDAQ:RXII) investors should be smiling today, after drug maker Opko Health (NASDAQ:OPK) disclosed in a SEC filing a 5.11% passive stake (446,360 shares) …

Analysts See Bright Days Ahead for Valeant Pharmaceuticals Intl Inc (VRX) and RXi Pharmaceuticals Corp (RXII)

As Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues to deal with bad press, one analyst believes there is nothing to worry about. On the …

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces the Initiation of a Phase 1/2 Trial in Ophthalmology with RXI-109 for Retinal Scarring

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today …

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces Compound Selection for Cosmetic Product Development with its Novel Self-delivering RNAi Platform

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced …

Biotech Beat: RXi Pharmaceuticals Corp (RXII), Zafgen Inc (ZFGN), Five Prime Therapeutics Inc (FPRX)

RXi Pharmaceuticals Corp On October 15, 2015, RXi Pharmaceuticals Corp (NASDAQ:RXII) announced positive phase 2a results for its RXI-109 compound. The trial, known …

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces Remarkable and Positive Results with its Novel Self-Delivering RNAi Platform

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced …

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces Positive Interim Results in Phase 2a Dermatology Program with RXI-109

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company that owns a broad intellectual property portfolio including a unique self-delivering RNAi platform, today announced that results from …

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp to Present at Premier Scientific Plastic Surgery Meeting

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced that …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts